Alterity Therapeutics Ltd ShareCafe Hidden Gems Webinar Transcript
Stop. We have Alterity Therapeutics Limited ASX: ATH, ATHE and they have a market cap of around 90 million. Our Alterity Therapeutics is a clinical-stage biotech company dedicated dedicated to creating an alternative future for living with neurodegenerative diseases.
Presenting for the company today is CEO, Dr. David Stamler. David, welcome to the network and over to you.
&
So thank you Paul, and thank you for all those attending in Australia and the US and elsewhere. And I am very happy to tell you about the great progress that we've made at Altegrity in 2023 and the excitement that we have for looking forward for the remainder of this year.
And next slide, these are forward-looking statements. I would encourage you to check our regulatory filings and Next slide. So as Paul mentioned, we are dedicated to finding an alternate future for people living with neurodegenerative diseases. And our mission is really in our name
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
